Suchergebnisse - "Sun, Chaoyang"

PubPharm (7)

1

WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway

enthalten in: The Journal of experimental medicine | 2022

von Guo, E. | Xiao, R. | Wu, Y. | +18

2

MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors

enthalten in: Cancer research | 2021

von Yang, B. | Li, X. | Fu, Y. | +14

3

Systems approach to rational combination therapy : PARP inhibitors

enthalten in: Biochemical Society transactions | 2020

von Sun, C. | Fang, Y. | Labrie, M. | +2

4

Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer

enthalten in: Cancer cell | 2020

von McGrail, D. | Garnett, J. | Yin, J. | +20

CommentIn: Cancer Discov. 2020 May;10(5):OF11. - PMID 32144094

5

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

enthalten in: Cancer cell | 2019

von Fang, Y. | McGrail, D. | Sun, C. | +24

CommentIn: Cancer Cell. 2019 Jun 10;35(6):821-822. - PMID 31185206

6

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency

enthalten in: Cancer cell | 2018

von Sun, C. | Yin, J. | Fang, Y. | +17

7

Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers

enthalten in: Science translational medicine | 2017

von Sun, C. | Fang, Y. | Yin, J. | +17

ErratumIn: Sci Transl Med. 2024 Mar 20;16(739):eadp0392. - PMID 38507471

1
[1]